Dirk G. Brockstedt
CHIEF SCIENTIFIC OFFICER · RAPT Therapeutics, Inc.
Individual
- 2024
- Mar 5, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Dirk G. Brockstedt's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dirk G. Brockstedt?
Dirk G. Brockstedt is a corporate insider, tracked as CHIEF SCIENTIFIC OFFICER of RAPT Therapeutics, Inc. (RAPT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dirk G. Brockstedt last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 2 filings going back to 2024.
